The Cancer Prevention Program ofthe Robert H. Lurie Comprehensive Cancer Center is a multi-disciplinary program focusing on three thematic areas: novel strategies for cancer risk stratification and early detection, innovative behavioral interventions to reduce cancer risk, and the discovery and development of new devices and therapeutics to reduce cancer risk. The Program Leader is Raymond Bergan, MD, an eminent molecular pharmacologist whose research focuses on cancer chemopreventive agents, and the Program Co-Leader is Bonnie Spring, PhD, a distinguished psychologist who studies behavioral risk factors. The objective ofthe Cancer Prevention Program, comprised of 28 faculty members from 11 departments and 3 schools, is to facilitate and focus research on primary and secondary cancer prevention within the Cancer Center. Between August 2007 and July 2012 there were 401 cancer-relevant publications from the Cancer Prevention Program members. Fifty-three (13.2%) of these publications represent intra-programmatic collaborations and 175 (43.6%) of these publications represent inter-programmatic collaborations. Further, a total of 6,247 individuals were entered on to Cancer Prevention Program studies, with 1,111 entered on to interventional trials. Total cancer relevant funding for the Prevention Program is $12,328,943, with 85% coming from peer reviewed funding. Peer reviewed funding is $10,466,682 (total) and $7,633,648 (direct), with $3,134,489 (41%) from NCI and $4,499,160 (59%) from national level peer reviewed sources. The goals ofthe Program are: i. to identify new methods of risk stratification and early detection, ii. to develop innovative strategies to reduce cancer risk behaviors, and iii. to discover and develop novel therapeutic approaches to reduce cancer risk. The contribution of prevention efforts to recent declines in cancer mortality, the demonstrated success of cancer chemopreventive agents, and evidence indicating that the large majority of cancers are caused by environmental factors (many of which are linked to behavior), coupled with the inherent humanitarian and economic logic of preventing cancer, all support the importance of this work. This Program actively seeks to expand the capabilities and efficacy of cancer prevention by developing and employing cutting edge technology, measurement tools and methods, and drug- and behavior-based interventional strategies. It does so by leveraging members'interests and capabilities across disciplines. The Program's integrated focus on cancer prevention provides an environment that fosters intra and inter-program collaboration, and has spawned cutting-edge advances in the field.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA060553-19
Application #
8588459
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2018-07-31
Budget Start
2013-09-16
Budget End
2014-07-31
Support Year
19
Fiscal Year
2013
Total Cost
$481,447
Indirect Cost
$169,878
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Zhao, J C; Fong, K-W; Jin, H-J et al. (2016) FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression. Oncogene 35:4335-44
Kaluzny, Joel; Purta, Patryk; Poskin, Zach et al. (2016) Ex Vivo Confocal Spectroscopy of Autofluorescence in Age-Related Macular Degeneration. PLoS One 11:e0162869
Marsh, Erica E; Chibber, Shani; Wu, Ju et al. (2016) Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma. Fertil Steril 105:1070-5
Zhao, Baobing; Mei, Yang; Schipma, Matthew J et al. (2016) Nuclear Condensation during Mouse Erythropoiesis Requires Caspase-3-Mediated Nuclear Opening. Dev Cell 36:498-510
Ridge, Karen M; Shumaker, Dale; Robert, Amélie et al. (2016) Methods for Determining the Cellular Functions of Vimentin Intermediate Filaments. Methods Enzymol 568:389-426
White, Sarah Beth; Procissi, Daniele; Chen, Jeane et al. (2016) Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases. PLoS One 11:e0155334
Cohee, Andrea A; Stump, Timothy; Adams, Rebecca N et al. (2016) Factors associated with depressive symptoms in young long-term breast cancer survivors. Qual Life Res 25:1991-7
Isabella, Adam J; Horne-Badovinac, Sally (2016) Rab10-Mediated Secretion Synergizes with Tissue Movement to Build a Polarized Basement Membrane Architecture for Organ Morphogenesis. Dev Cell 38:47-60
Valdovinos, Cristina; Penedo, Frank J; Isasi, Carmen R et al. (2016) Perceived discrimination and cancer screening behaviors in US Hispanics: the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study. Cancer Causes Control 27:27-37
Quinn, Gwendolyn P; Woodruff, Teresa K; Knapp, Caprice A et al. (2016) Expanding the Oncofertility Workforce: Training Allied Health Professionals to Improve Health Outcomes for Adolescents and Young Adults. J Adolesc Young Adult Oncol 5:292-6

Showing the most recent 10 out of 1027 publications